| pubmed-article:16988521 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16988521 | lifeskim:mentions | umls-concept:C0292818 | lld:lifeskim |
| pubmed-article:16988521 | lifeskim:mentions | umls-concept:C0687133 | lld:lifeskim |
| pubmed-article:16988521 | lifeskim:mentions | umls-concept:C0537439 | lld:lifeskim |
| pubmed-article:16988521 | lifeskim:mentions | umls-concept:C0663733 | lld:lifeskim |
| pubmed-article:16988521 | pubmed:issue | 15 | lld:pubmed |
| pubmed-article:16988521 | pubmed:dateCreated | 2006-9-21 | lld:pubmed |
| pubmed-article:16988521 | pubmed:abstractText | Fifty-five patients placed on tipranavir/ritonavir 500/200 mg twice a day (27 with enfuvirtide and 28 without) underwent tipranavir and ritonavir plasma concentration measurements by high-pressure liquid chromatography. Markedly higher tipranavir and ritonavir trough concentrations were observed in enfuvirtide recipients. The modelling of sparse plasma samples using a first order absorption and elimination monocompartmental model without time lag predicted higher tipranavir elimination half-life and volume of distribution in enfuvirtide takers. This unexpected drug-drug interaction warrants further investigation. | lld:pubmed |
| pubmed-article:16988521 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16988521 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16988521 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16988521 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16988521 | pubmed:issn | 0269-9370 | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:Di... | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:González de... | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:BonoraStefano... | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:SiniccoAlessa... | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:SciandraMauro... | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:D'AvolioAnton... | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:BargiacchiOli... | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:SiccardiMarco... | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:CalcagnoAndre... | lld:pubmed |
| pubmed-article:16988521 | pubmed:author | pubmed-author:LadettoLauraL | lld:pubmed |
| pubmed-article:16988521 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16988521 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:16988521 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:16988521 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16988521 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16988521 | pubmed:pagination | 1977-9 | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:meshHeading | pubmed-meshheading:16988521... | lld:pubmed |
| pubmed-article:16988521 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16988521 | pubmed:articleTitle | Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide. | lld:pubmed |
| pubmed-article:16988521 | pubmed:affiliation | Department of Infectious Diseases, University of Turin, Turin, Italy. | lld:pubmed |
| pubmed-article:16988521 | pubmed:publicationType | Journal Article | lld:pubmed |
